Solid Biosciences is a life science company focused on advancing a portfolio of neuromuscular and cardiac programs for the treatment of devastating diseases, including Duchenne, Friedreich’s ataxia, BAG3 mediated dilated cardiomyopathy, and additional cardiac diseases. We aim to be the center of excellence across the entire disease spectrum, serving as a catalyst to bring together those with the expertise in science, technology, disease management and care. Disease-focused and founded by a family directly impacted, our mandate is simple yet comprehensive - attack the roots of the disease and improve daily life for patients.
Solid is headquartered in Charlestown, MA, USA.
Company Details
- Employees
- 135
- Founded
- -
- Address
- 500 Rutherford Ave,
- Phone
- 16173374682
- in****@****bio.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- solidbio.com
- HQ
- Boston, Massachusetts
Solid Biosciences Questions
Solid Biosciences's helpline number is 16173374682
Solid Biosciences's website is solidbio.com
Solid Biosciences's LinkedIn profile is https://www.linkedin.com/company/solid-biosciences
Solid Biosciences has
135 employees.
View email and phone details for 135
employees at Solid Biosciences.
Solid Biosciences's industry is
Biotechnology Research
Solid Biosciences's top competitors are
Alnylam Pharmaceuticals,
Carbon Biosciences,
Aavantibio, Inc.,
Verve Therapeutics,
Beam Therapeutics,
Dyne Therapeutics,
Vertex Pharmaceuticals,
Sarepta Therapeutics,
Spyre Therapeutics,
Voyager Therapeutics, Inc..
Solid Biosciences's support email address is info@solidbio.com
Solid Biosciences's categories are Biotechnology Research
Solid Biosciences's founding year is 2013
